Breast Cancer Trial, Recruiting NCT05976815 Sponsor: University Institute of Maia Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT05976815
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are female
  • People who are 18 years of age or older
  • People who have been recently diagnosed with breast cancer (confirmed by tissue testing) at stages IA through IIIC
  • People who are planned to receive chemotherapy before surgery, using anthracycline or taxane-based drugs, which may also include targeted treatments for HER2-positive breast cancer
  • People who are being cared for by the oncology department at CHVNG/E (a specific hospital centre)
  • People whose cancer doctor has approved participation in a physical exercise program
  • People who are able to give written consent to take part in the study
  • People who agree to be randomly assigned to either the exercise group or the comparison group

Who may not be able to join:

  • People who have had a cancer diagnosis in the past
  • People who currently have another cancer diagnosis at the same time
  • People who have a physical or mental health condition that means exercise would not be safe or appropriate for them

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nuno Rato, MSc, University of Maia

Phone: +351 919985852

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Institute of Maia
Registry
ClinicalTrials.gov
Start date
31 July 2023
Est. completion
1 August 2026

Where this trial is recruiting

🇵🇹 Portugal

Primary endpoints

Pathologic Complete Response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov